Effects of a transtheoretical model based intervention and motivational interviewing on hyperphosphatemia management via telehealth among hemodialysis patients in COVID-19 pandemic situatio

Phase 2

Completed

• Conditions: Hyperphosphatemia management among hemodialysis patients in the COVID-19 pandemic situation; Hyperphosphatemia, hemodialysis patients, a transtheoretical model and motivational interviewing

• Registration Number: TCTR20230628003
• Lead Sponsor: /A

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2023-01-31
• Study Start: 2023-06-28
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

1. End-stage renal disease (ESRD) patients who have undergone hemodialysis for a minimum of 3 months.
2. Serum phosphate level greater than or equal to 5.5 mg/dL or an average serum phosphate level greater than or equal to 5.5 mg/dL over 3 months.
3. Adequate hemodialysis, determined by a Kt/V value greater than or equal to 1.8 for patients undergoing hemodialysis twice a week and a Kt/V value greater than or equal to 1.2 for patients undergoing hemodialysis three times a week.
4. No history of parathyroidectomy.
5. Ability to use Line application or other communication tools independently or with assistance to facilitate communication throughout the study.
6. No malnutrition, as assessed by the Malnutrition Inflammation Score (MIS).
7. Proficiency in the Thai language, including reading, writing, and comprehension.
8. Willingness and ability to actively participate in the study throughout its duration.

Exclusion Criteria

1.Change of address/relocation or move of domicile
2.Require hospitalization as a patient due to prolonged illness and unable to participate in program activities.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum phosphorus level 6 months Blood tests for checking the level of serum phosphorus and comparing the mean difference of serum phosphorus level (mg/dl) between intervention and control groups.

Secondary Outcome Measures

Name	Time	Method
The level of knowledge about the management of hyperphosphatemia, adherence to phosphate binders, and the level of dietary consumption behavior of foods containing phosphorus 6 months Questionnaires the score of knowledge about hyperphosphatemia management, medication adherence, and the dietary consumption behavior of foods containing phosphorus.